Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology Volume 273, Pages 1-7 (December 2018) DOI: 10.1016/j.ijcard.2018.07.143 Copyright © 2018 The Authors Terms and Conditions
Fig. 1 Kaplan–Meier survival curves for major adverse cardiovascular events, cardiovascular death, myocardial infarction, and stroke in patients with pulse pressure < 60 mmHg. Rates of freedom from major adverse cardiovascular events (A), cardiovascular death (B), myocardial infarction (C), and stroke (D). Major adverse cardiovascular events include cardiovascular death, myocardial infarction, and stroke. MACE, major adverse cardiovascular events. International Journal of Cardiology 2018 273, 1-7DOI: (10.1016/j.ijcard.2018.07.143) Copyright © 2018 The Authors Terms and Conditions
Fig. 2 Kaplan–Meier survival curves for major adverse cardiovascular events, cardiovascular death, myocardial infarction, and stroke in patients with pulse pressure ≥ 60 mmHg. Rates of freedom from major adverse cardiovascular events (A), cardiovascular death (B), myocardial infarction (C), and stroke (D). Major adverse cardiovascular events include cardiovascular death, myocardial infarction, and stroke. MACE, major adverse cardiovascular events. International Journal of Cardiology 2018 273, 1-7DOI: (10.1016/j.ijcard.2018.07.143) Copyright © 2018 The Authors Terms and Conditions